CI
DGX icon

Constellation Investments’s Quest Diagnostics DGX Stock Holding History

Constellation Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$229K Buy
3,200
+100
+3% +$6.71K 0.04% 397
2015
Q4 		$221K Buy
+3,100
New +$208K 0.04% 396
2015
Q3 		– Sell
-3,100
Closed -$225K – 419
2015
Q2 		$225K Hold
3,100
– – 0.04% 396
2015
Q1 		$238K Buy
+3,100
New +$222K 0.05% 386

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Constellation Investments's DGX Position: Q1 2016 in Review

Constellation Investments increased its Quest Diagnostics (DGX) stake by 3.2% in Q1 2016, buying an estimated $6.71K and bringing the position to 3,200 shares worth $229K. The position accounts for 0.04% of the portfolio, ranked #397.

Constellation Investments first reported a position in DGX in Q1 2015 and has held it in 4 quarters since. The position peaked at $238K in Q1 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • Constellation Investments held 3,200 shares of Quest Diagnostics worth $229K as of Q1 2016.
  • Constellation Investments bought 100 Quest Diagnostics shares in Q1 2016, an estimated $6.71K.
  • Quest Diagnostics made up 0.04% of Constellation Investments's portfolio in Q1 2016, its #397 holding.
  • Constellation Investments first reported a position in Quest Diagnostics in Q1 2015 and has held it in 4 quarters since.
  • Constellation Investments's Quest Diagnostics position peaked at $238K in Q1 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.